← FDA Drug Approvals (Drugs@FDA)
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2022-03-01
Drug application
- FDA Application #
ANDA212472- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
- Generic name
- Doxylamine Succinate
- Active ingredients
- DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ACTAVIS LABS FL INC
- First approval
- 2022-03-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown